2.47
6.93%
0.16
Sangamo Therapeutics Inc (SGMO) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
76.44%
0.481
|
2.042 | 9.398 | 6.835 | 157.96 |
Operating Expenses
|
18.87%
52.01
|
64.10 | 115.81 | 130.41 | 139.92 |
Benefits Costs and Expenses |
20.98%
49.47
|
62.61 | 112.29 | 127.61 | 136.63 |
Costs And Expenses |
20.98%
49.47
|
62.61 | 112.29 | 127.61 | 136.63 |
Operating Income/Loss |
16.97%
-51.53
|
-62.06 | -106.41 | -123.57 | 18.03 |
Income/Loss From Continuing Operations Before Tax |
19.11%
-48.99
|
-60.57 | -102.89 | -120.77 | 21.33 |
Income Tax Expense/Benefit |
136.03%
0.098
|
-0.272 | 1.27 | -6.264 | 0.194 |
Income/Loss From Continuing Operations After Tax |
18.59%
-49.09
|
-60.30 | -104.16 | -114.51 | 21.13 |
Net Income/Loss
|
18.59%
-49.09
|
-60.30 | -104.16 | -114.51 | 21.13 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
16,770%
180.34
|
1.069 | 177.17 | 174.32 | 168.53 |
Diluted Average Shares |
16,770%
180.34
|
1.069 | 177.17 | 174.32 | 169.18 |
Basic Earnings Per Share |
20.59%
-0.27
|
-0.34 | -0.59 | -0.66 | 0.13 |
Diluted Earnings Per Share |
20.59%
-0.27
|
-0.34 | -0.59 | -0.66 | 0.12 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):